Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.56 USD | -2.30% | -2.88% | -5.08% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.08% | 1.78B | |
+31.18% | 695B | |
+26.51% | 568B | |
-4.60% | 361B | |
+19.69% | 330B | |
+3.87% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+8.93% | 168B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Mizuho Securities Cuts Price Target on Harmony Biosciences to $40 From $42, Maintains Buy Rating